Glean’s latest priced round in late 2025 established a $7.2 billion post-money valuation after a $150 million Series F, while secondary-market prints as of October 2026 have eased to roughly $6.9 billion. Rapid ARR expansion to an estimated $300 million by mid-2026, more than tripling from the prior year, continues to support enterprise-AI multiples near 24x, yet the absence of a new primary round or material secondary uptick leaves the near-term path dependent on any late-October transaction prints or investor marks. With resolution only weeks away, traders are monitoring secondary liquidity and any disclosed funding activity that could shift the mark above or below prevailing thresholds before month-end.